- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05820308
Companion Dog Walking for ICU Survivor Health (POOCH)
Feasibility and Acceptability of a Randomized Controlled Trial Comparing a Companion Dog-Walking Intervention to an Attention Control Education Intervention on the Psychological Health of Adult Intensive Care Unit Survivors
The goal of this clinical trial is to determine the feasibility and acceptability of a randomized controlled trial comparing a pet dog walking intervention to an attention control education intervention in adult intensive care unit survivors.
The main question[s] it aims to answer are:
- What is the feasibility of a pet dog-walking intervention compared to an attention control education intervention on depression, anxiety, cortisol, and quality of life for adult ICU survivors.
- What is the acceptability of a pet dog-walking intervention compared to an attention control education intervention on depression, anxiety, cortisol, and quality of life for adult ICU survivors.
The secondary question[s] it aims to answer are:
- What are the differences in depression, anxiety, serum cortisol, and quality of life between and within a companion dog walking intervention compared to an attention control education intervention for ICU survivors?
Participants in the intervention group will be asked to:
- Participate in dog walking with their pet dog at least three times per week, for at least 10 minutes each walk, for 8-weeks.
- Wear an activity monitor and record their dog walks in a diary.
- Complete surveys to measure depression, anxiety, and quality of life at the start of the study, after week 4, and after week 8.
- Have blood drawn to measure cortisol levels at the start of the study, after week 4, and after week 8.
Participants in the control group will be asked to:
- Read educational materials about their pet dog's health once every week (education materials are provided by the researchers).
- Wear an activity monitor and record when they read their education materials in a diary.
- Complete surveys to measure depression, anxiety, and quality of life at the start of the study, after week 4, and after week 8.
- Have blood drawn to measure cortisol levels at the start of the study, after week 4, and after week 8.
Participants will be assigned to an intervention group or a control group to see if there are differences in depression, anxiety, serum cortisol, and quality of life.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lindsey Nelson, MSN, RN
- Phone Number: 719-255-4484
- Email: lnr2m@mail.umkc.edu
Study Locations
-
-
Colorado
-
Colorado Springs, Colorado, United States, 80907
- Recruiting
- Penrose Hospital
-
Colorado Springs, Colorado, United States, 80923
- Recruiting
- St. Francis Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult (≥18 years)
- ICU survivors (spent ≥24 hours in the ICU)
- Will be discharged directly home from hospital.
- Able to speak, read, and understand English
- Physically capable of dog walking
- Individuals who have symptoms of depression and/or anxiety
- Individuals who own a companion dog and walk their dog <10 minutes/week
- Participants scoring ≤ 20 seconds on the TUG Test
Exclusion Criteria:
- Individuals at high risk for suicide
- Individuals with severe depression or anxiety
- Individuals who recently started treatment for depression and/or anxiety
- Individuals with cognitive impairment
- Dog walking is deemed unsafe with and for the dog
- Medical Provider authorization is indicated but not provided
- Individuals who live outside a 45-mile radius of Colorado Springs.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Group
Companion dog walking
|
Participants will be asked to walk their dog three times per week, for a minimum of 30 minutes each day of walking, over an 8-week period.
|
Active Comparator: Attention Control Group
Educational resources about dog health
|
Participants will be asked to read educational materials on dog health once per week, over an 8-week period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Study Feasibility as assessed by recruitment results, attrition rates, intervention fidelity, and missing data points
Time Frame: Feasibility data will be collected and analyzed from the time identifying, screening, and recruiting eligible participants begins to the time the final participant completes the study; no more than 12 months.
|
Data will be collected to answer the following questions:
|
Feasibility data will be collected and analyzed from the time identifying, screening, and recruiting eligible participants begins to the time the final participant completes the study; no more than 12 months.
|
Study Acceptability as assessed by participant responses to survey questions regarding the amount of time spent in the study, the measurement tools used, the masking procedure, and the intervention.
Time Frame: Acceptability will be assessed post-intervention after participants complete the 8-week study period.
|
Participants will complete an exit survey and will be asked to report on: (1) the acceptability of the time spent in the study and per session, (2) the acceptability of completing the measurement tools, (3) the acceptability of the masking procedure, (4) the acceptability of the intervention, (5) if they intend to continue the intervention after the end of the study, and (6) to report any suggestions for improvement they have.
|
Acceptability will be assessed post-intervention after participants complete the 8-week study period.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Depression
Time Frame: Depression will be measured at baseline, half way through the intervention (at the end of week 4), and post intervention (at the end of week 8).
|
The Center for Epidemiologic Studies Depression Scale is a 20-item self-report tool that assesses intensity of depression using a 4-point Likert scale.
Lower scores indicate milder levels of depression while higher scores indicate more severe depression (potential score 0-60).
Clinically meaningful depression is represented by a score of 16 or greater.
|
Depression will be measured at baseline, half way through the intervention (at the end of week 4), and post intervention (at the end of week 8).
|
Change in Anxiety
Time Frame: Anxiety will be measured at baseline, half way through the intervention (at the end of week 4), and post intervention (at the end of week 8).
|
The Spielberger State Trait Anxiety Inventory is a 40-item self-report assessment tool using a 4-point Likert scale that assesses both trait and state anxiety.
The higher a participant's score (potential score 20-80 on each subscale) the higher the level of anxiety.
No/low anxiety = 20-37 points; moderate anxiety= 38-44 points; and high anxiety=45-80 points, with a cut-off point of 39 indicting clinically significant symptoms of anxiety.
|
Anxiety will be measured at baseline, half way through the intervention (at the end of week 4), and post intervention (at the end of week 8).
|
Change in Quality of Life as assessed by health related quality of life indicators including physical functioning, physical and emotional limitations, social functioning, bodily pain, general and mental health.
Time Frame: Quality of life will be measured at baseline, half way through the intervention (at the end of week 4), and post intervention (at the end of week 8).
|
The Short Form 36 is a 36-item self-report questionnaire using various ranking questions to measure health related quality of life.
The Shot Form 36 examines eight dimensions of health related quality of life (physical functioning, physical and emotional limitations, social functioning, bodily pain, general and mental health).
The higher the score (max score =100) the better the health and wellbeing, the lower the score (minimum score=0) the poorer the health and wellbeing.
|
Quality of life will be measured at baseline, half way through the intervention (at the end of week 4), and post intervention (at the end of week 8).
|
Change in Serum Cortisol
Time Frame: Serum Cortisol will be measured at baseline, half way through the intervention (at the end of week 4), and post intervention (at the end of week 8).
|
Peripheral venous blood samples will be obtained from participants or analysis at a laboratory.
|
Serum Cortisol will be measured at baseline, half way through the intervention (at the end of week 4), and post intervention (at the end of week 8).
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Lindsey Nelson, MSN, RN, University of Missouri, Kansas City
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2094468
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Companion Dog Walking
-
Oregon State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruitingPhysical Activity | Social ResponsibilityUnited States
-
University of PlymouthCompletedWellbeing | Dementia | Aging | Neuropsychiatric SymptomsUnited Kingdom
-
Copenhagen Studies on Asthma in ChildhoodCompleted
-
University of AarhusCompletedPhysiological Stress Responses to Standardises Stress Situations | Psychological Responses to Standardised Stress Situations | Behavioural Responses to Standardised Stress SituationsDenmark
-
Indiana UniversityRecruitingAnxiety | Children | Opioid Use | Therapy DogUnited States
-
Swiss Tropical & Public Health InstituteUniversity of BaselCompleted
-
University of Maryland, BaltimoreCompletedPost Traumatic Stress DisorderUnited States
-
Children's Hospital Medical Center, CincinnatiEunice Kennedy Shriver National Institute of Child Health and Human Development...UnknownBrain Injuries | Traumatic Brain Injury | Acquired Brain InjuryUnited States
-
University of Alabama at BirminghamNot yet recruitingElbow InjuryUnited States
-
Northeastern UniversityActive, not recruitingPhysical Activity | ExerciseUnited States